Dr. Lal Pathlabs Ltd

NSE: LALPATHLAB · BSE: 539524 · Healthcare · 56 announcements

Share price: ₹1,938.00
Market cap: ₹32,529 Cr
Revenue (annual): ₹2,763 Cr
Net profit (annual): ₹504.8 Cr
P/E (TTM): 60.0×Sector 53.1×
Promoter holding: 53.19%-0.02% QoQ
FII holding: 17.35%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Acquisition 7 Other Announcement 4 Employee Stock Options 2 Merger & Restructuring 1 Capital Structure Change 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

19 Aug 2026 18:24 IST BSE

Merger & Restructuring

Dr. Lal Pathlabs Merger & Restructuring

Dr. Lal PathLabs' subsidiary, Dr Lal PathLabs FZCO, has incorporated a new step-down subsidiary, Dr Lal PathLabs Indomed LLC, in Tashkent, Uzbekistan, acquiring a 70% stake.

Read the filing ↗